NIO reports better-than-expected second-quarter results and expects third-quarter 2024 vehicle deliveries in the range of 61,000-63,000 units.
Vous n'êtes pas connecté
Beam Therapeutics (BEAM) reports mixed second-quarter results. The company remains focused on pipeline development.
NIO reports better-than-expected second-quarter results and expects third-quarter 2024 vehicle deliveries in the range of 61,000-63,000 units.
VIRC's second-quarter fiscal 2024 results benefit from higher factory output and improved operating efficiencies, along with a significant...
VIRC's second-quarter fiscal 2024 results benefit from higher factory output and improved operating efficiencies, along with a significant...
RH's second-quarter fiscal 2024 results reflect strong demand despite a challenging housing market.
Dave & Buster's fiscal second-quarter results benefit from remodeled locations, new menu and pricing tests for games, and food and beverage offerings.
DKS posts robust second-quarter fiscal 2024 results, thanks to the solid execution of its strategic efforts.
DOCU's second-quarter fiscal 2025 earnings and revenues increase year over year.
DLTR posts soft second-quarter fiscal 2024 results due to a challenging macro backdrop.
DLTR posts soft second-quarter fiscal 2024 results due to a challenging macro backdrop.
PD's second-quarter fiscal 2025 results benefit from an expanding customer base. However, weak top-line guidance negatively impacts share price.